Erica Ollmann Saphire takes the helm
See a problem, take action. That’s how she was raised
A cold case no longer
What happened when an LJI scientist revisited a diabetes mystery
Immune cells can detect cancer
Now we can see what they see — and help
How I see LJI
A letter from President and CEO Erica Ollmann Saphire, Ph.D.
Letter from the Board Chair – Fall 2021
A letter from Eric Zwisler, Chair, La Jolla Institute for Immunology Board of Directors
Beauty in science
Mexican sculptor assembles an emotional tribute to COVID-19 research
Lynn Hedrick and Klaus Ley named “World Experts” in monocyte research
Immune cells called monocytes offer clues to treating cancers, heart disease and more
Lungs of COVID-19 survivors teem with virus-fighting ‘memory’ cells
Even elderly survivors show a strong, persistent immune memory
Annie Elong Ngono | Life Without Disease Stories
Annie Elong Ngono, Ph.D., is an infectious disease specialist at La Jolla Institute for Immunology, where she works to find
Joel Martin named Managing Director and Chief Business Officer at La Jolla Institute for Immunology
LA JOLLA, CA—Joel Martin, Ph.D., MBA, has joined La Jolla Institute for Immunology (LJI) as Managing Director and Chief Business
From Alpha to Epsilon: Consortium study illuminates surfaces of Spike most resistant to antibody escape
LJI-led Coronavirus Immunotherapeutic Consortium identifies antibody 'communities' with power to stop SARS-CoV-2 variants
In Autoimmune Disease, Organs May Lure the Immune System into an Attack
New evidence indicates that target cells may play a role in their own destruction.